Home › NDC Lookup › Ingredients › Miconazole Nitrate › 70000-0679-01
Antifungal Powder Miconazole Nitrate 20 mg/g Powder, 71 g — NDC 70000-0679-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Antifungal Powder Miconazole Nitrate 20 mg/g Powder, 71 g — NDC 70000-0679-1 (Billing 70000-0679-01)

by LEADER/ Cardinal Health 110, Inc. · 71 g in 1 BOTTLE, PLASTIC

This is a package of 71 g of Antifungal Powder Miconazole Nitrate 20 mg/g Powder from LEADER/ Cardinal Health 110, Inc., marketed since Aug 2024 and currently FDA-listed; retail pharmacies pay about $0.0579 per g (NADAC). It is this product's only package size.

NDC 70000-0679-01
🏷️ FDA NDC (as labeled) 70000-0679-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70000-0679-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
70000 labeler · 0679 product · 1 package
Package marketed since
Aug 16, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
71 g per package
Barcode (UPC)
0096295143508
Medicaid fills, this package
1,948 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Miconazole Nitrate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 10, 2024 — Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0315-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0679-1
Product NDC 70000-0679
11-digit billing NDC 70000067901
NCPDP billing unit GM — per gram (weight)
RxCUI 998461
UNII VW4H1CYW1K
UPC 0096295143508
Application # M005
SPL Set ID 1fcf072b-cf12-967a-e063-6294a90acfc7
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-08-16
Route TOPICAL
Dosage form POWDER
Substance MICONAZOLE NITRATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90154050102910
GCN Seq No 007367
GCN 30410
HICL code 003031
Ingredient (HICL) Miconazole Nitrate
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 84:04.08.08
AHFS class Azoles (Skin And Mucous Membrane)
FDB label name ANTIFUNGAL 2% POWDER
FDB brand name Antifungal Powder
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007367
  • GCN: 30410
  • GPI-14 (Medi-Span): 90154050102910
  • HICL (First Databank): 003031
  • AHFS class code: 84:04.08.08
  • RxCUI (RxNorm): 998461
Why two NDCs? The FDA registers this code as 70000-0679-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0679-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Imidazole derivatives, Imidazole and triazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ANTIFUNGAL 2% POWDER Ingredient Miconazole Nitrate
📖 What it is MedlinePlus · NLM

Topical miconazole is used to treat tinea corporis(ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), and tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes). Miconazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection. Not all products should be used to treat all of these conditions. Please read the label for each product to select the one to treat your conditi...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats fungal and yeast infections. Depending on the product, that means vaginal yeast infections, athlete's foot, jock itch, ringworm, or thrush in the mouth and throat (Oravig...
  • Apply it to your upper gum in the morning after brushing, with dry hands. Hold it in place for 30 seconds. Don't crush, chew or swallow it. Use it once a day for 14 days.
  • Most are mild, like diarrhea, nausea, headache, upper belly pain or a change in taste. Vaginal products may cause mild burning or itching at first. Stop and get help for hives, tro...
  • Tell me if you take warfarin. Miconazole can boost its blood-thinning effect, so watch for bleeding or bruising. With Oravig, oral diabetes medicines, phenytoin and ergot alkaloids...
📖 Read our full Miconazole guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.058 $4.11 / 71 g
Medicaid paysCMS SDUD · 12 mo $0.1312 $9.32 / 71 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.058 $0.056
▲ Up 3% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0679-01 You're viewing this Main listing 71 g in 1 BOTTLE, PLASTIC 2024-08-16 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Miconazorb AF 20 mg/g 46122-0789-29 AmerisourceBergen 71 g $0.058 — Availability likely —
Miconazole Nitrate 1.42 g/71g 70000-0323-01 LEADER/ 71 g $0.058 — Discontinued —
Antifungal Powder 20 mg/gthis 70000-0679-01 LEADER/ 71 g $0.058 — Availability likely —
Desenex 20 mg/g 00316-0225-15 Crown 43 g — — Discontinued —
Zeasorb Athletes Foot 20 mg/g 00316-8000-01 Crown 71 g — — FDA listed —
Zeasorb Jock Itch 20 mg/g 00316-8001-02 Crown 71 g — — FDA listed —
Foot Powder 20 mg/g 00363-7999-01 Walgreens 71 g — — FDA listed —
Jock Itch Powder 20 mg/g 00363-9223-01 Walgreens 71 g — — FDA listed —
Miconazole Nitrate Antifungal Powder 2 g/100g 10135-0720-85 Marlex 85 g — — FDA listed —
Lotrimin AF Jock Itch 20 mg/g 11523-0150-01 Bayer 177 g — — FDA listed —
Lotrimin Antifungal 20 mg/g 11523-0919-01 Bayer 90 g — — FDA listed —
Micro-Guard (AF) 20 mg/g 11701-0038-16 Coloplast 85 g — — FDA listed —
Anti-Fungal Powder 20 mg/g 30142-0947-71 The 71 g — — FDA listed —
Miconazole Nitrate 1.42 g/71g 36800-0385-25 Topco 71 g — — Discontinued —
Anti-Fungal Powder 20 mg/g 36800-0613-01 TopCo 71 g — — FDA listed —
Miconazole Nitrate 2 g/100g 42291-0938-85 AvKARE 85 g — — FDA listed —
Anti-Fungal Powder 20 mg/g 51316-0980-01 CVS 71 g — — FDA listed —
Remedy Antifungal 2 g/100g 53329-0169-79 Medline 85 g — — FDA listed —
Miconazole Nitrate 20 mg/g 53943-0976-01 Discount 71 g — — FDA listed —
ProCure Antifungal 2 g/100g 55681-0043-03 Twin 85 g — — FDA listed —
Anti- Fungal Miconazole Nitrate 1.42 g/71g 56104-0253-01 Premier 71 g — — FDA listed —
Anti-fungal Powder Miconazole Nitrate 20 mg/g 56104-0500-00 Premier 71 g — — FDA listed —
Medicated Athletes Foot Powder 20 mg/g 56104-0906-01 Premier 99 g — — FDA listed —
Mycozyl AP 2 g/85g 59088-0442-07 PureTek 85 g — — FDA listed —
Micotrin AP 2 g/85g 59088-0478-07 PureTek 85 g — — FDA listed —
1236-CS Antifungal Powder (Talc Free) 20 mg/g 67777-0313-04 Dynarex 24 bottles — — FDA listed —
THERA Antifungal Body 20 mg/g 68599-0207-03 McKesson 85 g — — FDA listed —
GeriGentle Miconazole nitrate 2 g/100g 69771-0165-03 GERI-GENTLE 85 g — — FDA listed —
Miconazole Nitrate 1.42 g/71g 69842-0490-25 CVS 71 g — — FDA listed —
Miconazole Nitrate 1.42 g/71g 72446-0007-71 Hudson 71 g — — FDA listed —
Miconazole Nitrate 20 mg/g 72446-0014-01 Hudson 71 g — — FDA listed —
DCH Labs Antifungal Jock 2 g/100g 72839-0096-02 Derma 71 g — — FDA listed —
Warrior Antifungal Foot 2 g/100g 72839-0961-02 Derma 71 g — — FDA listed —
Anti-fungal Powder Miconazole Nitrate 20 mg/g 79481-0621-01 Meijer 71 g — — FDA listed —
Antifungal 20 mg/g 80513-0771-03 Advanced 85 g — — FDA listed —
Evercare Antifungal Treatment Super Absorbent Powder 20 mg/g 83099-0000-00 PANEFFORT, 85 g — — FDA listed —
Dermachange Jock 2 g/100g 83520-0961-02 Private 71 g — — FDA listed —
Happy Nuts Jock Itch Powder 2 g/100g 87151-0111-01 Suit 71 g — — FDA listed —
Antifungal Powder 2 g/100g 87236-0012-03 Aldermed 85 g — — FDA listed —
Jock Itch Powder 20 mg/g 56104-0122-01 Premier 127 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Aug 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Miconazole inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 344S277G0Z
    Allantoin is a naturally derived compound that helps soften and soothe skin. In medicines, it works as a skin-conditioning agent and may help support wound healing and reduce irritation in topical formulations.
  • UNII 0F32U78V2Q
    Chloroxylenol is a synthetic antimicrobial chemical used as a preservative in medicines and personal care products. It prevents bacterial and fungal growth to help keep the medication safe and effective during storage.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 8MDF5V39QO
    A white powder form of baking soda that acts as a buffer and pH regulator in medicines. It helps maintain the right acid-base balance and may aid tablet disintegration.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII K4C08XP666
    A mineral salt made from calcium and phosphate. It acts as a filler to add bulk and texture to tablets and powders, and also helps stabilize and bind ingredients together.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesZea Mays (Corn) Starch, Tricalcium Phosphate, Microcrystalline Cellulose, Sodium Bicarbonate, Allantoin, Chloroxylenol, Fragrance

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerLEADER/ Cardinal Health 110, Inc.
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedAug 2024
Product typeHuman Otc Drug
Portfolio38 products on file

More NDCs from LEADER/ Cardinal Health 110, Inc. labeler code 70000

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 15 words ▾

Uses for the cure of most athlete's foot, ringworm and chafing associated with jock itch

⏱️ Dosage and Administration 96 words ▾

Directions clean the affected area and dry thoroughly apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, & change shoes & socks at least once daily for athlete's foot & ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks if conditions persist longer, consult a doctor this product is not effective on the scalp or nails

⚠️ Warnings 75 words ▾

Warnings For external use only. Do not use on children under 2 years of age unless directed by a doctor. When using this product avoid contact with the eyes Stop and ask a doctor if irritation occurs or there is no improvement within 4 weeks for athlete's foot and ringworm, or 2 weeks for jock itch. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words ▾

Active ingredient Miconazole nitrate 2%

🧪 Inactive Ingredients 15 words ▾

Inactive ingredients Zea Mays (Corn) Starch, Tricalcium Phosphate, Microcrystalline Cellulose, Sodium Bicarbonate, Allantoin, Chloroxylenol, Fragrance

🎯 Purpose 2 words ▾

Purpose Antifungal

📄 Do Not Use 15 words ▾

Do not use on children under 2 years of age unless directed by a doctor.

📄 When Using This Product 9 words ▾

When using this product avoid contact with the eyes

📄 Stop Use and Ask a Doctor If 27 words ▾

Stop and ask a doctor if irritation occurs or there is no improvement within 4 weeks for athlete's foot and ringworm, or 2 weeks for jock itch.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 14 words ▾

Other information store between 59º - 86ºF lightly shake bottle to loosen settled powder

📄 Questions or Comments 3 words ▾

Questions? Call 1-866-964-0939

📄 Package Label / Principal Display Panel 36 words ▾

Principal Display Panel LEADER Moisture Absorbing Antifungal Powder Miconazole Nitrate 2%/ Antifungal Cures Most Athlete's Foot Relieves Itching, Burning & Scaling Absorbs Moisture COMPARE TO ZEASORB AF active ingredient NET WT

2.5 OZ (71 g) carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.9K
Units reimbursed last 4 qtrs
140K
Gross reimbursed last 4 qtrs
$18.4K
Avg / prescription
$9.43
Avg / unit
$0.1312
Latest quarter Q1 2026
673Rx
Medicaid pays / g
$0.1312
gross reimbursed
vs
NADAC / g
$0.0579
acquisition cost
=
Spread
+$0.0733
+127% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
32% FFS 68% MCO
Fee-for-service · 616 Rx Managed care · 1,332 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 15,948 units · 278 per 100k residents MN Wisconsin: 19,823 units · 335 per 100k residents WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 4,700 units · 111 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 9,699 units · 141 per 100k residents IN Ohio: 17,613 units · 149 per 100k residents OH Pennsylvania: 19,626 units · 151 per 100k residents PA New Jersey: 8,264 units · 89.0 per 100k residents NJ Massachusetts: 3,706 units · 52.9 per 100k residents MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 21,967 units · 1,111 per 100k residents NE Missouri: 1,207 units · 19.5 per 100k residents MO Kentucky: 6 units · 0.1 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: 5,893 units · 163 per 100k residents CT Rhode Island: no data reported RI Arizona: 2,627 units · 35.4 per 100k residents AZ New Mexico: no data reported NM Kansas: 8,889 units · 302 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
0.11,111
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Nebraska 1,111 /100k
2 Wisconsin 335 /100k
3 Kansas 302 /100k
4 Minnesota 278 /100k
5 Connecticut 163 /100k
6 Pennsylvania 151 /100k
7 Ohio 149 /100k
8 Indiana 141 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Miconazole 3 (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Miconazole 3. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$35.6K
Claims incl. refills
725
Beneficiaries
649
Spend / beneficiary
$54.91
Spend / claim
$49.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Antifungal Powder (this brand).

Top reported reactions

Vulvovaginal Burning Sensation242
Vulvovaginal Pain79
Condition Aggravated77
Vulvovaginal Pruritus73
Drug Interaction64
Vulvovaginal Discomfort47
Dyspnoea45

Reporter sex

1,517 reports
Male · 27%
Female · 73%
Unknown · 0%

Serious outcomes

Life-threatening55
Disabling30
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 155 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 70000-0677-01 · Cardinal 70000-0680-01 · LEADER/Cardinal →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.